Literature DB >> 6958362

Purine modulation of methotrexate cytotoxicity in mammalian cell lines.

I W Taylor, P Slowiaczek, P R Francis, M H Tattersall.   

Abstract

The modulation of MTX cytotoxicity by purines has been studied in a number of mammalian cell lines. In each case, it was found that exogenous purines (guanosine, deoxyguanosine, adenosine, deoxyadenosine, and hypoxanthine) both reduced and potentiated MTX cytotoxicity depending on the MTX concentration. At low MTX concentrations (less than 6 X 10(-8) M), purines reduced MTX toxicity and at higher concentrations they potentiated MTX toxicity. The reduction of low-concentration MTX cytotoxicity by purines was associated with the reversal of MTX-induced changes in deoxyribonucleotide pools. On the other hand, potentiation of MTX toxicity by purines was associated with substantial increases in deoxyadenosine 5'-triphosphate levels in conjunction with low deoxythymidine 5'-triphosphate levels. The magnitude of increase in deoxyadenosine 5'-triphosphate levels tended to correlate with the degree of potentiation which varied between 5-fold and 200-fold, depending on cell type and the exogenous purine.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6958362

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  Accumulation of DNA strand breaks and methotrexate cytotoxicity.

Authors:  J C Li; E Kaminskas
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

2.  Enhanced cytotoxicity with methotrexate in conjunction with hypoxanthine in L1210 cells in culture.

Authors:  C R Fairchild; J Maybaum; J A Straw
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

3.  Inhibition of 5-aminoimidazole-4-carboxamide ribotide transformylase, adenosine deaminase and 5'-adenylate deaminase by polyglutamates of methotrexate and oxidized folates and by 5-aminoimidazole-4-carboxamide riboside and ribotide.

Authors:  J E Baggott; W H Vaughn; B B Hudson
Journal:  Biochem J       Date:  1986-05-15       Impact factor: 3.857

4.  DNA fragmentation, dATP pool elevation and potentiation of antifolate cytotoxicity in L1210 cells by hypoxanthine.

Authors:  J B Kwok; M H Tattersall
Journal:  Br J Cancer       Date:  1992-04       Impact factor: 7.640

5.  The ability to accumulate deoxyuridine triphosphate and cellular response to thymidylate synthase (TS) inhibition.

Authors:  S D Webley; S J Welsh; A L Jackman; G W Aherne
Journal:  Br J Cancer       Date:  2001-08-03       Impact factor: 7.640

6.  Preclinical cellular pharmacology of LY231514 (MTA): a comparison with methotrexate, LY309887 and raltitrexed for their effects on intracellular folate and nucleoside triphosphate pools in CCRF-CEM cells.

Authors:  V J Chen; J R Bewley; S L Andis; R M Schultz; P W Iversen; C Shih; L G Mendelsohn; D E Seitz; J L Tonkinson
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

7.  Modulation of antifolate cytotoxicity by metabolites from dying cells in a lymphocyte clonal assay.

Authors:  J M Hughes; A deFazio; M H Tattersall
Journal:  Br J Cancer       Date:  1988-05       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.